Telisotuzumab Antibody
Telisotuzumab (ABT-700) is a humanized anti-c-MET monoclonal antibody that potently inhibits MET signaling pathways. It has demonstrated antitumor activity in preclinical models, supporting its investigation in oncology research, particularly for MET-dysregulated cancers, in both in vitro and in vivo experimental settings.
Product Specifications
Product Name Alternative
Mab-224G11, HGFR, ABT 700, ABT700, ABT-700, c-Met, cMet, cMet/HGFR, Telisotuzumab
Target
C-Met/HGFR, Apoptosis
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Cell Biology, Signal Transduction
Concentration
4.71 mg/mL
Purity
96.10% (May vary between batches)
Molecular Weight
145.50 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC881125-500 1x 500 µL
Arginase 1 (Hepatocellular Carcinoma Marker) (ARG1/1125), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC941429-100 1x 100 µL
E-Cadherin / CD324 (Intercellular Junction Marker) (4A2), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 